OHSU scientists have created an open-access database cataloging lipid-protein interactions, providing biomedical researchers worldwide with a tool that could accelerate drug discovery and disease understanding. The database systematically maps how lipid molecules interact with proteins — relationships that underpin cellular signaling, inflammation, and metabolic regulation but have been far less studied than protein-protein or protein-DNA interactions.

Lipids are central to a vast range of diseases: cardiovascular disease, diabetes, neurodegeneration, and cancer all involve lipid metabolism dysregulation. Yet lipid biology has historically lagged behind genomics and proteomics in terms of organized, searchable data infrastructure. OHSU's database fills that gap, enabling researchers to identify potential drug targets by querying which lipid-protein interactions are disrupted in specific disease states. This is foundational infrastructure work — the kind of resource that doesn't generate headlines but enables hundreds of downstream discoveries.

For Oregon's research and healthcare community, this tool reinforces OHSU's role as a producer of enabling scientific infrastructure, not just clinical research papers. Pharmaceutical and biotech companies evaluating Oregon as a research hub will take note of resources like this. Clinically, the database has long-term implications for precision medicine — understanding a patient's lipid-protein interaction profile could eventually inform drug selection and dosing. In the near term, OHSU investigators across multiple departments will likely use the database to generate preliminary data for NIH grant applications, strengthening the institution's competitive position for federal research funding.

Watch for early publications citing the database and whether OHSU parlays this tool into collaborative research partnerships with pharmaceutical companies.